Introduction Vaccination requires innovation to provide effective protection. Traditional
vaccines have several drawbacks, which can be overcome with advanced technologies and …

Liposomes are widely utilized as a carrier to improve therapeutic efficacy of agents thanks to
their merits of high loading capacity, targeting delivery, reliable protection of agents, good …

Introduction Liposomes have been used as carriers for vaccine adjuvants and antigens due
to their inherent biocompatibility and versatility as delivery vehicles. Two vial admixture of …

Liposomes (phospholipid bilayer vesicles) are versatile and robust delivery systems for
induction of antibody and T lymphocyte responses to associated subunit antigens. In the last …

Liposomes are versatile delivery systems and immunological adjuvants that not only can
load various antigens, such as proteins, peptides, nucleic acids and carbohydrates, but also …

Liposomes as a drug delivery system are well established with around 15 products in
clinical use. However, liposomes also offer a range of advantages for the delivery of …

Introduction: Liposomes remain at the forefront of drug and vaccine design owing to their
well-documented abilities to act as delivery vehicles. Nevertheless, the concept of liposomes …

Liposomes not only offer the ability to enhance drug delivery, but can effectively act as
vaccine delivery systems and adjuvants. Their flexibility in size, charge, bilayer rigidity and …

The development of subunit vaccines has become very attractive in recent years due to their
superior safety profiles as compared to traditional vaccines based on live attenuated or …

Among the various particulate delivery systems, liposomes—bubble-like nano/microsized
lipidic bilayer structures—have shown great promise as an antigen-carrying vehicle. Few …